A phase I/II study of ALIMTA (pemetrexed) in patients with relapsed or refractory acute leukaemia or lymphoid blast phase CML [chronic myeloid leukaemia]
Phase of Trial: Phase I/II
Latest Information Update: 23 Jan 2006
At a glance
- Drugs Pemetrexed (Primary)
- Indications Leukaemia
- Focus Adverse reactions; Therapeutic Use
- 23 Jan 2006 New trial record.